8-K/AExhibits & Filings

CARDINAL HEALTH INC 8-K/A Report, Exhibit Filing (Jun 15, 2007)

Filed June 15, 2007For Securities:CAH

Summary

This filing is an Amendment No. 2 to a Current Report (8-K/A) for Cardinal Health Inc. (CAH), filed on June 14, 2007, relating to events that occurred on April 25, 2007. The primary purpose of this amendment is to revise the Management's Discussion and Analysis (MD&A) section of its 2006 Form 10-K annual report. These revisions are in response to comments received from the Securities and Exchange Commission's (SEC) Division of Corporation Finance, aiming to provide further information, quantification, and updated disclosures. Investors should note that this 8-K/A is a supplementary filing intended to correct or enhance previous disclosures, not to introduce new material events. It directs readers to consult the original 2006 Form 10-K, the April 26, 2007 Form 8-K, and subsequent quarterly filings for a comprehensive understanding of the company's financial condition and results of operations. The core of this amendment is an exhibit containing a revised Item 7 (MD&A) of the 2006 Form 10-K.

Key Highlights

  • 1Amendment No. 2 to Current Report (8-K/A) filed by Cardinal Health Inc. (CAH).
  • 2The filing primarily revises the Management's Discussion and Analysis (MD&A) section of the 2006 Form 10-K.
  • 3Revisions are made in response to comments from the SEC's Division of Corporation Finance.
  • 4The amendment provides further information, quantification, and revised disclosures.
  • 5This filing is an update to previous reports, including an 8-K filed on April 26, 2007.
  • 6Investors are advised to review this amendment in conjunction with prior filings (2006 10-K, April 26, 2007 8-K, and subsequent 10-Qs).

Frequently Asked Questions

The main purpose of this 8-K/A filing is to amend and revise the Management's Discussion and Analysis (MD&A) section of Cardinal Health's 2006 Form 10-K. These revisions are a response to specific comments and requests for additional information from the SEC's Division of Corporation Finance.

No, this filing is primarily an amendment to provide enhanced disclosures and clarifications on previously reported information, particularly within the MD&A. It does not appear to introduce new material events or financial results but rather refines the existing disclosures based on SEC feedback.

Investors should review this 8-K/A in conjunction with the original 2006 Form 10-K, the previously filed 8-K dated April 26, 2007, and Cardinal Health's subsequent Quarterly Reports on Form 10-Q for the periods ended September 30, 2006, December 31, 2006, and March 31, 2007, as well as other SEC filings.

The filing specifically revises Item 7 of Part II of the 2006 Form 10-K, which corresponds to the Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A).